Importantly, the presence of ANA correlates with elevated S1‐specific antibodies in COVID‐19 patients during acute phase (46), and 20-30% of COVID-19 patients display serum ANA levels above the threshold typically associated with SjD (8). The gene discussed is PSMD1; the disease is COVID-19.